POET trades 52.7% above Wall Street's consensus target of $5.75.
Last 12 months price action with 12-month analyst target path
The base valuation assumes POET achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, POET Technologies Inc. (POET) has a Wall Street consensus price target of $5.75, based on estimates from 2 covering analysts. With the stock currently trading at $12.15, this represents a potential downside of -52.7%. The company has a market capitalization of $1.60B.
Analyst price targets range from a low of $3.50 to a high of $8.00, representing a 78% spread in expectations. The median target of $5.75 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, POET trades at a trailing P/E of -17.9x. Analysts expect EPS to grow +53.9% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
IPGPIPG Photonics Corporation | $5.0B | $118.01 | $151.50 | +28.4% | Buy | 92.9x | 27 |
LITELumentum Holdings Inc. | $60.7B | $850.00 | $985.82 | +16.0% | Buy | 103.7x | 25 |
COHRCoherent, Inc. | $61.8B | $389.57 | $324.00 | -16.8% | Buy | 71.4x | 30 |
AAOIApplied Optoelectronics, Inc. | $12.8B | $161.85 | $160.00 | -1.1% | Buy | 156.6x | 16 |
SLABSilicon Laboratories Inc. | $7.2B | $219.75 | $211.60 | -3.7% | Buy | 79.4x | 37 |
VIAVViavi Solutions Inc. | $10.9B | $47.17 | $32.25 | -31.6% | Buy | 50.3x | 19 |
IPARInter Parfums, Inc. | $3.2B | $99.09 | $112.00 | +13.0% | Buy | 20.3x | 19 |
NVDANVIDIA Corporation | $5.1T | $210.69 | $316.79 | +50.4% | Buy | 23.6x | 79 |
INTCIntel Corporation | $672.8B | $133.99 | $89.08 | -33.5% | Hold | 123.6x | 84 |
AVGOBroadcom Inc. | $2.0T | $411.35 | $498.19 | +21.1% | Buy | 35.5x | 58 |
Quick answers to the most common questions about buying POET stock.
POET's consensus price target is $5.75, -52.7% below the current price of $12.15. The 2 analysts tracking POET see downside risk at present valuations.
POET has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $5.75 implies -52.7% downside from current levels.
POET's current price is $12.15 with a consensus target of $5.75 (-52.7% implied move). Analyst estimates suggest the stock is overvalued at current levels.
The most bullish Wall Street analyst has a price target of $8 for POET, while the most conservative target is $3.5. The consensus of $5.75 represents the median expectation. These targets typically reflect 12-month expectations.
POET is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month POET stock forecast based on 2 Wall Street analysts shows a consensus price target of $5.75, with estimates ranging from $3.5 (bear case) to $8 (bull case). The median consensus rating is "Buy".
Analysts are cautious on POET, with 0 Sell ratings and a price target of $5.75 (-52.7% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
POET analyst price targets range from $3.5 to $8, a 78% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $5.75 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.